231 related articles for article (PubMed ID: 8993844)
21. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Burnier M
Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
[TBL] [Abstract][Full Text] [Related]
22. The renin-angiotensin system and the developing retinal vasculature.
Sarlos S; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
[TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin system in transgenic rats: characteristics and functional studies.
Wagner J; Ganten D
Semin Nephrol; 1993 Nov; 13(6):586-92. PubMed ID: 8278693
[No Abstract] [Full Text] [Related]
24. Targeting genes in the renin-angiotensin system.
Le TH; Coffman TM
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):57-63. PubMed ID: 18090671
[TBL] [Abstract][Full Text] [Related]
25. Activated and inactivated renin-angiotensin system in transgenic animals: from genes to blood pressure.
Fukamizu A; Murakami K
Lab Anim Sci; 1997 Apr; 47(2):127-31. PubMed ID: 9150489
[TBL] [Abstract][Full Text] [Related]
26. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
Tamura J; Konno A; Hashimoto Y; Kon Y
Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
[TBL] [Abstract][Full Text] [Related]
28. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
Peters J; Hilgers KF; Maser-Gluth C; Kreutz R
Clin Exp Hypertens; 1996 Oct; 18(7):933-48. PubMed ID: 8886477
[TBL] [Abstract][Full Text] [Related]
29. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
30. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
Springate J; Van Liew J; Ganten D
Kidney Blood Press Res; 1997; 20(1):1-5. PubMed ID: 9192903
[TBL] [Abstract][Full Text] [Related]
31. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.
Flesch M; Höper A; Dell'Italia L; Evans K; Bond R; Peshock R; Diwan A; Brinsa TA; Wei CC; Sivasubramanian N; Spinale FG; Mann DL
Circulation; 2003 Aug; 108(5):598-604. PubMed ID: 12874189
[TBL] [Abstract][Full Text] [Related]
32. Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
Bachmann S; Peters J; Engler E; Ganten D; Mullins J
Kidney Int; 1992 Jan; 41(1):24-36. PubMed ID: 1593860
[TBL] [Abstract][Full Text] [Related]
33. Genetic targeting of the brain renin-angiotensin system in transgenic rats: impact on stress-induced renin release.
Baltatu O; Campos LA; Bader M
Acta Physiol Scand; 2004 Aug; 181(4):579-84. PubMed ID: 15283773
[TBL] [Abstract][Full Text] [Related]
34. The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27.
Sander M; Bader M; Djavidani B; Maser-Gluth C; Vecsei P; Mullins J; Ganten D; Peters J
Endocrinology; 1992 Aug; 131(2):807-14. PubMed ID: 1322284
[TBL] [Abstract][Full Text] [Related]
35. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.
Lee MA; Böhm M; Paul M; Bader M; Ganten U; Ganten D
Am J Physiol; 1996 Jun; 270(6 Pt 1):E919-29. PubMed ID: 8764174
[TBL] [Abstract][Full Text] [Related]
36. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
Bader M; Zhao Y; Sander M; Lee MA; Bachmann J; Böhm M; Djavidani B; Peters J; Mullins JJ; Ganten D
Hypertension; 1992 Jun; 19(6 Pt 2):681-6. PubMed ID: 1592468
[TBL] [Abstract][Full Text] [Related]
37. [Role of renin angiotensin system in the vasopressor mechanisms of hypertension--gene analyses and tissue renin angiotensin system].
Nishimura M; Yoshimura M
Rinsho Byori; 1995 Nov; 43(11):1128-32. PubMed ID: 8551676
[TBL] [Abstract][Full Text] [Related]
38. The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects.
Langheinrich M; Lee MA; Böhm M; Pinto YM; Ganten D; Paul M
Am J Hypertens; 1996 May; 9(5):506-12. PubMed ID: 8735183
[TBL] [Abstract][Full Text] [Related]
39. The effects of repeated delivery of angiotensin II AT(1) receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals.
Vaněčková I; Dobešová Z; Kuneš J; Zicha J
Hypertens Res; 2012 Jul; 35(7):761-8. PubMed ID: 22399098
[TBL] [Abstract][Full Text] [Related]
40. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
Lee MA; Böhm M; Kim S; Bachmann S; Bachmann J; Bader M; Ganten D
Hypertension; 1995 Apr; 25(4 Pt 1):570-80. PubMed ID: 7721400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
